Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice

Nature Medicine

Volumn 4, Issue 10, 1998, Pages 1189-1192

  Praticò, Domenico ^a   Tangirala, Rajendra K ^a   Rader, Daniel J ^a   Rokach, Joshua ^b   Fitzgerald, Garret A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Florida Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DIET SUPPLEMENTATION; LIPID OXIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHOLESTEROL; DINOPROST; ISOMERISM; MICE; MICE, MUTANT STRAINS; OXIDATIVE STRESS; VITAMIN E;

ANIMALIA;

EID: 0031752607     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/2685     Document Type: Article

References (27)

1. Steinberg, D. Oxidative modification of LDL and atherogenesis. Circulation 95, 1062-1071 (1997).
2. Haberland, M.E., Fong, D. & Cheng, L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241, 215-218 (1988).
3. Palinski, W. et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86, 1372-1376 (1989).
4. Navab, M. et al. The Yin and Yan of oxidation in the development of the fatty streak. Arterioscl. Thromb. Vasc. Biol. 16, 831-842 (1996).
5. Kuhn, H., Belkner, J., Zaiss, S., Fahrenklemper, T. & Wohlfeil, S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179, 1911-1994 (1994).
6. Ylä-Herttuala, S. et al. Co-localization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 87, 6959-6963 (1987).
7. Patrono, C. & FitzGerald, G.A. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease. Arterioscl. Thromb. Vasc. Biol. 17, 2309-2315 (1997).
8. 2-isoprostanes in human atherosclerotic lesions. J. Clin. Invest. 100, 2027-2034 (1997).
9. 2α is increased in hypercholesterolemia. Arterioscl. Thromb. Vasc. Biol. 17, 3230-3235 (1997).
10. Rokach, J. et al. Nomenclature of lsoprostanes: a proposal. Prostaglandins 54, 853-873 (1997).
11. Steinberg D. Clinical trials of antioxidants and atherosclerosis : are we doing the right thing? Lancet 346, 36-38 (1995).
12. Gutteridge, J.M.C. & Halliwell, B. The measurement and mechanism of lipid peroxidation in biological systems . Trends Biochem. Sci. 15, 129-1365 (1990).
13. Fruebis, J., Bird, D.A., Pattison, J. & Palinski, W. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J. Lipid Res. 38, 2455-2464 (1997).
14. Tangirala, R.K. et al. Effect of the antioxidant N,N'-Diphenyl 1,4-Phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. Arterioscl. Thromb. Vasc. Biol. 15, 1625-1630 (1995).
15. Santanam, M. & Parthasarathy, S. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases. J. Clin. Invest. 95, 2594-2600 (1995).
16. Zhang, S.H. et al. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. J. Clin. Invest. 99, 2858-2866 (1997).
17. Bird, D.A. et al. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice. J. Lipid Res. 39, 1079-1090 (1998).
18. Fruebis, J., Carew, T.E. & Palinski, W. Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits. Atherosclerosis 117, 617-626 (1995).
19. Hayek, T. et al. Probucol decreases apolipoprotein A-1 transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein a-I transgenic mice. Atheroscler. Thromb. 11: 1295-1302 (1991).
20. 2-isoprostanes. Agents Actions 48, 26-41 (1997).
21. 2α-I: A novel index of lipid peroxidation in humans. Proc. Natl. Acad. Sci. USA 95, 3449-3454 (1998).
22. Plump, A.S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343-353 (1992).
23. Zhang, S.H., Reddick, R.L., Piedrahita, J.A. & Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468-471 (1992).
24. Palinski, W. et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscl. Thromb. Vasc. Biol. 14, 605-616 (1994).
25. Tangirala, R.K., Rubin, E.M. & Palinski, W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36, 2320-2328 (1995).
26. 2 isoprostanes in hypercholesterolemia. Circulation (in the press).
27. Praticò, D. et al. Increased lipid peroxidation in hepatic cirrhosis, J. Investig. Med. 46, 51-57 (1998).